ARCHIVES

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010